BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 3489155)

  • 41. Analgesic use by leprosy patients.
    Segasothy M; Muhaya HM; Musa A; Rajagopalan K; Lim KJ; Fatimah Y; Kamal A; Ahmad KS
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):399-402. PubMed ID: 3746043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of analgesic nephropathy in Belgium.
    Vanherweghem JL; Even-Adin D
    Clin Nephrol; 1982 Mar; 17(3):129-33. PubMed ID: 7067174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analgesic nephropathy: an important cause of chronic renal failure.
    Cove-Smith JR; Knapp MS
    Q J Med; 1978 Jan; 47(185):49-69. PubMed ID: 674550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathology, aetiology and pathogenesis of analgesic nephropathy.
    Nanra RS
    Aust N Z J Med; 1976; 6 Suppl 1():Suppl 1:33-7. PubMed ID: 1070995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy.
    Gonwa TA; Hamilton RW; Buckalew VM
    Arch Intern Med; 1981 Mar; 141(4):462-5. PubMed ID: 7212889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse.
    Bluemle LW; Goldberg M
    J Clin Invest; 1969 Nov; 47(11):2507-14. PubMed ID: 5813230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia.
    Nanra RS; Stuart-Taylor J; de Leon AH; White KH
    Kidney Int; 1978 Jan; 13(1):79-92. PubMed ID: 362034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analgesic nephropathy.
    Henrich WL
    Trans Am Clin Climatol Assoc; 1998; 109():147-58; discussion 158-9. PubMed ID: 9601134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phenacetin abuse II. Chronic renal insufficiency in Basle autopsies].
    Mihatsch MJ; Schmidlin P; Brunner FP; Hofer HO; Six P; Zollinger HU
    Schweiz Med Wochenschr; 1980 Jan; 110(4):116-24. PubMed ID: 6987731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for the nephrotoxicity of analgesics.
    Gault MH
    Can Med Assoc J; 1972 Oct; 107(8):756-8. PubMed ID: 4638851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geographical distribution of cancers of the kidney and urinary tract and analgesic nephropathy in Australia and New Zealand.
    McCredie M; Coates MS; Ford JM; Disney AP; Auld JJ; Stewart JH
    Aust N Z J Med; 1990 Oct; 20(5):684-8, 694. PubMed ID: 2285384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract.
    Gonwa TA; Corbett WT; Schey HM; Buckalew VM
    Ann Intern Med; 1980 Aug; 93(2):249-52. PubMed ID: 7406375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible role of laxatives in analgesic nephropathy.
    Wainscoat JS; Finn R
    Br Med J; 1974 Dec; 4(5946):697-8. PubMed ID: 4441864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is phenacetin responsible for analgesic nephropathy in New South Wales?
    McCredie M; Stewart JH; Mahony JF
    Clin Nephrol; 1982 Mar; 17(3):134-40. PubMed ID: 7067175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Causes and consequences of long term consumption of phenacetin-containing analgesics, from the urologist's point of view (author's transl)].
    Porpáczy P
    Wien Klin Wochenschr Suppl; 1979; 104():1-21. PubMed ID: 384682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetaminophen and adverse chronic renal outcomes: an appraisal of the epidemiologic evidence.
    Barrett BJ
    Am J Kidney Dis; 1996 Jul; 28(1 Suppl 1):S14-9. PubMed ID: 8669423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analgesic nephropathy and the renal concentrating mechanism.
    Burry A; Cross R; Axelsen R
    Pathol Annu; 1977; 12 Pt 2():1-31. PubMed ID: 341056
    [No Abstract]   [Full Text] [Related]  

  • 58. Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis.
    Stewart JH; Hobbs JB; McCredie MR
    Cancer; 1999 Oct; 86(8):1576-82. PubMed ID: 10526288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analgesic nephropathy and phenacetin-induced transitional cell carcinoma - analysis of 300 patients with long-term consumption of phenacetin-containing drugs.
    Porpáczy P; Schramek P
    Eur Urol; 1981; 7(6):349-54. PubMed ID: 7286004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analgesic nephropathy].
    Mihatsch MJ; Zollinger HU
    Zentralbl Allg Pathol; 1986; 132(5-6):395-411. PubMed ID: 3551393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.